Unichem Laboratories aims $ 100 mn revenue from US

The Mumbai-based pharmaceutical company Unichem Laboratories is aiming to achieve $ 100 million revenue from the US, its fastest growing overseas market, by focusing on complex generics and first-to-file (Para IV) products. “Inspite of being a late entrant in the US, we have already crossed $40 million last year. And in terms of milestones, we would like to cross $50 million in the current year and $ 100 million in the coming years. For the company, US remains the fastest growing market and $ 100 million would be our first target before looking at the next target of $ 500